angiotensin ii has been researched along with exendin 3 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cahill, C; Geraldes, P; Hiraoka-Yamomoto, J; King, GL; Kitada, M; Li, C; Li, Q; Matsumoto, M; Mima, A; Mizutani, K; Nishikawa, S; Park, K; Rask-Madsen, C | 1 |
1 other study(ies) available for angiotensin ii and exendin 3
| Article | Year |
|---|---|
Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCĪ² activation in diabetes.
Topics: Angiotensin II; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelium; Exenatide; Gene Expression Regulation; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Kidney Glomerulus; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptides; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-raf; Receptors, Glucagon; RNA Interference; Signal Transduction; Tissue Culture Techniques; Venoms | 2012 |